Back
Perspective Therapeutics Stock Predictions
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.
Sell
43
CATX
Perspective Therapeutics
Last Price:
$3.1700
Seasonality Move:
9048.28%
7 Day Trial
ALL ACCESS PASS
$
7
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.Perspective Therapeutics Stock Forecast
-
Is Perspective Therapeutics Stock Undervalued?The current Perspective Therapeutics [CATX] share price is $3.2200. The Score for CATX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Perspective Therapeutics Stock Go Up Next Year?
Data Unavailable
Perspective Therapeutics Stock Rating
Data Unavailable
Perspective Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com
52-Week Data
52-Week High:
16.5500
52-Week Low:
1.6000
Prediction Charts
Market Cap:
239M
Price in USD:
3.2200
Volume:
525K
Beta:
-72.5377
Technical Analysis
SMA50:
2.4388
SMA100:
2.6641
SMA200:
5.9171
52-Wk Change:
-75.79%
Stock Predictions
-
Is Perspective Therapeutics stock public?Yes, Perspective Therapeutics is a publicly traded company.
-
What is the Perspective Therapeutics stock quote today?The Perspective Therapeutics stock price is 3.2200 USD today.
-
How to buy Perspective Therapeutics stock online?You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-23 | 2.5100 | 2.3900 | 2.5550 | 2.3900 |
| May-27 | 2.4800 | 2.4000 | 2.5450 | 2.3400 |
| May-28 | 2.4000 | 2.5800 | 2.6850 | 2.4000 |
| May-29 | 2.6000 | 2.7000 | 2.7550 | 2.6000 |
| May-30 | 2.6700 | 2.5700 | 2.7700 | 2.5250 |
| Jun-2 | 2.6800 | 2.3900 | 2.7100 | 2.3400 |
| Jun-3 | 2.4400 | 3.0900 | 3.6600 | 2.4400 |
| Jun-4 | 3.2100 | 3.1300 | 3.3800 | 3.0500 |
| Jun-5 | 3.1000 | 3.1200 | 3.3500 | 2.9600 |
| Jun-6 | 3.2100 | 3.3200 | 3.5700 | 3.1600 |
| Jun-9 | 3.4300 | 3.2300 | 3.6000 | 3.2300 |
| Jun-10 | 3.2500 | 3.4300 | 3.7000 | 3.2500 |
| Jun-11 | 3.5200 | 3.2800 | 3.6600 | 3.2500 |
| Jun-12 | 3.4000 | 3.2200 | 3.4100 | 3.1611 |
Perspective Therapeutics Earnings
Data Unavailable
Perspective Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.17 per share.
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.